化学家卢茨·阿克曼获得拜耳基金会的汉森家族奖-动脉网

Chemist Lutz Ackermann Receives Bayer Foundation’s Hansen Family Award

拜耳等信源发布 2025-10-16 16:09



可切换为仅中文







October

十月

2025

09:59 AM

09:59 上午

Europe/Amsterdam

欧洲/阿姆斯特丹

Chemist Lutz Ackermann Receives Bayer Foundation’s Hansen Family Award

化学家卢茨·阿克曼获得拜耳基金会的汉森家族奖

2025-0147

Portrait Lutz Ackermann, Copy Right: Werner Siemens Stiftung/ Felix Wey

卢茨·阿克曼肖像，版权：维尔纳·西门子基金会/费利克斯·韦伊

Download Media Kit

下载媒体工具包

Preparing your download...

正在准备您的下载...

Download

下载

An error occurred while preparing your download

准备下载时发生错误

Groundbreaking Research Awarded

开创性研究获奖

Summary

摘要

Ackermann develops methods for producing active medical ingredients more precisely, efficiently, and sustainably / Four emerging talents receive “Early Excellence in Science Award”

阿克曼开发了更精确、更高效、更可持续地生产活性医药成分的方法 / 四位新兴人才荣获“科学早期卓越奖”

Leverkusen, October 16, 2025

勒沃库森，2025年10月16日

– Chemist Prof. Dr. Lutz Ackermann from the Georg-August University Göttingen is awarded the €75,000 Hansen Family Award from the Bayer Foundation this year. The prize honors Ackermann's research in sustainable chemistry, organic synthesis, and catalysis. Additionally, Dr. Casey Paquola, Dr. Simon Lebek, Dr.

－来自哥廷根大学的化学教授卢茨·阿克曼博士今年被授予拜耳基金会颁发的75,000欧元汉森家族奖。该奖项表彰阿克曼在可持续化学、有机合成和催化领域的研究。此外，凯西·帕奎拉博士、西蒙·莱贝克博士、

Anna Wuttig, and Dr. Britta Velten receive the “Early Excellence in Science Award” as emerging talents in Life Sciences..

安娜·乌蒂希和布里塔·韦尔滕博士因在生命科学领域的杰出表现，荣获“科学新秀奖”。

The Hansen Family Award is awarded every two years by the corporate foundation Bayer Foundation. The prize was created thanks to generous donations from the estate of Kurt Hansen, the former chairman of Bayer’s Supervisory Board. To date, 13 researchers have received the prize, including Emmanuelle Charpentier, Nobel laureate and scientist in the field of genome editing.

汉森家族奖由拜耳基金会每两年颁发一次。该奖项的设立得益于拜耳监事会前主席库尔特·汉森遗产的慷慨捐赠。迄今为止，已有13名研究人员获此殊荣，其中包括诺贝尔奖得主、基因组编辑领域的科学家埃马纽埃尔·卡彭蒂耶。

The “Early Excellence in Science Award”, established in 2009, has since honored 47 young talents in the Life Sciences. It includes a prize money of €10,000 for each recipient..

“科学早期卓越奖”设立于2009年，至今已表彰了47位生命科学领域的年轻才俊，每位获奖者将获得1万欧元的奖金。

Ackermann develops reaction techniques for improving medications

阿克曼开发了改善药物的反应技术。

For 20 years, Lutz Ackermann has been developing and refining molecular research. Carbon-hydrogen compounds play a key role in this. The bond between carbon and hydrogen forms the backbone of organic molecules. These bonds are so strong that they can hardly be broken in a targeted and precise way. However, if successful, a new functional group can be attached to this point.

二十年来，卢茨·阿克曼一直在发展和完善分子研究。碳氢化合物在此领域中扮演着关键角色。碳和氢之间的键构成了有机分子的主链。这些键非常牢固，很难以有针对性且精确的方式断裂。然而，一旦成功，就可以在这个位置连接一个新的官能团。

In this way, the structure of a molecule can be precisely and specifically changed — and with it, its properties, such as solubility or degradation in the body. This allows new active ingredients to be developed and tested faster. “It's somewhat like playing with Lego,” explains Ackermann, professor at the Georg-August University Göttingen.

通过这种方式，可以精确且特异性地改变分子的结构——同时改变其性质，如溶解性或在体内的降解性。这使得新的活性成分能够更快地被开发和测试。“这有点像玩乐高积木，”哥廷根大学乔治-奥古斯特大学的阿克曼教授解释道。

“We take a molecule — our Lego construction — and swap out a piece at a certain point. This allows us to change the molecule and even create structures that didn't exist before.”.

“我们选取一个分子——我们的乐高构造——并在某个点替换掉其中的一部分。这使我们能够改变分子，甚至创造出之前不存在的结构。”

The reaction techniques developed by Ackermann, known as C-H activations, are widely applicable. 'The only requirement to use this technique is that a molecule has a carbon-hydrogen bond. Complex anti-cancer agents or therapeutic proteins can be specifically modified and thus efficiently improved at the desired location.

阿克曼开发的被称为C-H活化的反应技术具有广泛的应用性。 “使用该技术的唯一要求是分子具有碳氢键。复杂的抗癌药物或治疗性蛋白质可以被特定地修饰，从而在所需位置有效地进行改进。”

While conventional syntheses often require ten to fifteen steps, the change with C-H activation succeeds in just one step — saving time and resources such as solvents and producing less waste.'.

传统的合成方法通常需要十到十五个步骤，而使用C-H键活化的转变仅需一步即可完成——节省了时间和溶剂等资源，同时产生的废物更少。

As of now, no drug modified using this method has reached the market yet. However, together with other researchers in various scientific fields, Ackermann is advancing the application, for example, to improve efficiency in the development of new cancer drugs. At the same time, Ackermann aims to make chemical processes more sustainable.

截至目前，尚无通过这种方法改良的药物上市。然而，阿克曼正与其他各科学领域的研究人员共同推进该方法的应用，例如提高新抗癌药物开发的效率。同时，阿克曼的目标是使化学工艺更加可持续。

He and his team are researching catalysts that are necessary to make complicated modifications to molecules..

他和他的团队正在研究催化剂，这些催化剂对于对分子进行复杂修饰是必要的。

Chitkala Kalidas, Executive Director of the Bayer Foundation & Head of ESG (Environmental, Social, Governance) at Bayer: “The Hansen Family Award is conferred in recognition of exceptional scientific contributions that hold the potential to catalyze breakthrough innovations in medicine and allied disciplines.

拜耳基金会执行董事兼拜耳ESG（环境、社会、治理）主管奇特卡拉·卡利达斯表示：“汉森家族奖旨在表彰那些有潜力推动医学及相关领域突破性创新的杰出科学贡献。

Professor Lutz Ackermann’s pioneering research serves as the basis to significantly advance the development of novel cancer therapies, offering hope to millions of patients worldwide.”.

路茨·阿克曼教授的开创性研究为显著推进新型癌症疗法的发展奠定了基础，为全球数百万患者带来了希望。

Four emerging talents receive “Early Excellence in Science Award”

四位后起之秀荣获“科学新锐奖”

Alongside the Hansen Family Award, the Bayer Foundation also awards the “Early Excellence in Science Award” in the categories of biology, chemistry, medicine, and data science. This award recognizes the inspiring work of young researchers who are pioneering in their fields. Casey Paquola from the Jülich Research Center receives the prize in biology for her research on simulating human brain maturation, which can help identify abnormalities in brain development earlier.

除了汉森家族奖外，拜耳基金会还颁发生物学、化学、医学和数据科学领域的“科学早期卓越奖”。该奖项旨在表彰在各自领域中开拓创新的年轻研究人员的鼓舞人心的工作。于利希研究中心的凯西·帕奎拉因她在模拟人类大脑成熟方面的研究而获得生物学奖，这项研究有助于更早识别大脑发育异常。

Simon Lebek, working at the University Hospital Regensburg, is awarded in the category of medicine for his work on gene-editing technologies for the treatment of cardiovascular diseases. Chemist Anna Wuttig at the University of Chicago receives the award for advancing electrocatalysis for energy storage, conversion, and medicinal chemistry.

西蒙·莱贝克在雷根斯堡大学医院工作，他因在心血管疾病治疗的基因编辑技术方面的工作获得医学类奖项。芝加哥大学的化学家安娜·伍蒂希因推动用于能量储存、转换和医药化学的电催化技术而获奖。

Britta Velten from the University of Heidelberg impressed the independent jury of the Bayer Foundation with her research in machine learning and data sciences to enable new insights into health and disease..

海德堡大学的布里塔·费尔滕因其在机器学习和数据科学领域的研究，为健康与疾病提供了新的见解，给拜耳基金会的独立评审团留下了深刻印象。

All awardees will be recognized in an award ceremony in February 2026 held in Leverkusen. An overview of all previous award recipients of the Bayer Foundation Science Awards can be found on the

所有获奖者都将在2026年2月于勒沃库森举行的颁奖典礼上受到表彰。拜耳基金会科学奖所有往届获奖者的概述可在以下网站找到：

Bayer Foundation website

拜耳基金会网站

。

About the Bayer Foundation

关于拜耳基金会

Bayer Foundation, Bayer's corporate foundation, creates sustainable impact by supporting breakthroughs in social innovation and science to create a world with 'Health for All, Hunger for None.' The foundation enables rising social entrepreneurs, researchers, students, as well as impact organizations engaged in the fields of health and food security, to achieve their goals.

拜耳基金会是拜耳的公司基金会，通过支持社会创新和科学领域的突破，创造可持续的影响，致力于实现“人人健康，无人饥饿”的世界。该基金会助力新兴社会企业家、研究人员、学生以及从事健康和粮食安全领域的影响力组织实现他们的目标。

The Bayer Foundation’s flagship programs include the annual “Women Entrepreneurs Award” and the “Fellowship Program” for students and doctoral candidates in the life sciences. In addition, the “Science Awards” honor established researchers for their long-term research achievements as well as outstanding emerging talents..

拜耳基金会的旗舰项目包括一年一度的“女性创业者奖”以及面向生命科学领域学生和博士生的“研究员计划”。此外，“科学奖”表彰在长期研究中取得成就的资深研究人员，以及表现突出的新锐人才。

Find more information at

查找更多信息，请访问

www.bayer.com

。

Forward-Looking Statements

前瞻性声明

This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here.

本发布可能包含基于拜耳管理层当前假设和预测的前瞻性声明。各种已知和未知的风险、不确定性和其他因素可能导致公司实际未来结果、财务状况、发展或业绩与这里给出的估计存在重大差异。

These factors include those discussed in Bayer’s public reports which are available on the Bayer website at .

这些因素包括在拜耳的公开报告中讨论的因素，这些报告可在拜耳网站上查阅。

www.bayer.com

. The company assumes no liability whatsoever to update these forward-looking statements or to conform

公司不承担更新这些前瞻性声明或使其符合的任何责任 whatsoever

them to future events or developments.

将它们应用于未来的事件或发展。

Contact

联系

Jana op den Winkel

扬娜·奥彭登克尔